EYE » Topics » EXHIBIT INDEX

This excerpt taken from the EYE 8-K filed Feb 27, 2009.

EXHIBIT INDEX

 

Exhibit No.

  

Description

3.1    Amended and Restated Certificate of Incorporation of Abbott Medical Optics Inc., dated as of February 26, 2009.
3.2    Amended and Restated Bylaws of Abbott Medical Optics Inc., adopted as of February 26, 2009.
4.1    Supplemental Indenture, dated as of February 26, 2009, between Abbott Medical Optics Inc. and U.S. Bank National Association, as trustee (relating to the 1.375% Convertible Senior Subordinated Notes).
4.2    Supplemental Indenture, dated as of February 26, 2009, between Abbott Medical Optics Inc. and U.S. Bank National Association, as trustee (relating to the 2.50% Convertible Senior Subordinated Notes).
4.3    Second Supplemental Indenture, dated as of February 26, 2009, between Abbott Medical Optics Inc. and U.S. Bank National Association, as trustee (relating to the 3.25% Convertible Senior Subordinated Notes).
99.1    Fundamental Change Repurchase Notice to holders of Abbott Medical Optics Inc.’s 1.375% Convertible Senior Subordinated Notes due 2025, dated as of February 27, 2009.
99.2    Fundamental Change Repurchase Notice to holders of Abbott Medical Optics Inc.’s 2.50% Convertible Senior Subordinated Notes due 2024, dated as of February 27, 2009.
99.3    Fundamental Change Repurchase Notice to holders of Abbott Medical Optics Inc.’s 3.25% Convertible Senior Subordinated Notes due 2026, dated as of February 27, 2009.
99.4    Press release announcing fundamental change repurchase offers dated February 27, 2009.
99.5    Press release announcing the consummation of the Merger dated February 26, 2009.
This excerpt taken from the EYE 8-K filed Feb 25, 2009.

EXHIBIT INDEX

 

Exhibit No.

  

Description

  4.1    Second Supplemental Indenture, dated as of February 25, 2009, among Advanced Medical Optics, Inc., the guarantors party thereto and Wilmington Trust Company, as trustee.
99.1    Press release of Advanced Medical Optics, Inc. announcing the acceptance of Notes pursuant to the Notes Offer dated February 25, 2009.
99.2    Press release of Abbott Laboratories announcing the acceptance of Shares pursuant to the Offer dated February 25, 2009.
This excerpt taken from the EYE 8-K filed Feb 20, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release, dated February 20, 2009, issued by Advanced Medical Optics, Inc.

 

4


This excerpt taken from the EYE 8-K filed Feb 17, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

2.1

 

Amendment No. 1 to Merger Agreement, dated as of February 17, 2009, by and among the Company, Parent and Purchaser

99.1

 

Memorandum of Understanding, dated as of February 14, 2009, in relation to In re Advanced Medical Optics, Inc. Shareholder Litigation, Case No. 30-2009-00236910.

 

4


This excerpt taken from the EYE 8-K filed Jan 27, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated January 27, 2009 of Advanced Medical Optics, Inc.

 

4


This excerpt taken from the EYE 8-K filed Oct 31, 2008.

EXHIBIT INDEX

 

Exhibit No.     
99.1    Press release, dated October 31, 2008, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Oct 20, 2008.

EXHIBIT INDEX

 

Exhibit
No.

    
99.1    Press release, dated October 20, 2008, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Oct 9, 2008.

EXHIBIT INDEX

 

Exhibit
No.

    
99.1    Press release, dated October 9, 2008, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Aug 26, 2008.

EXHIBIT INDEX

 

Exhibit
No.

    
99.1    Unaudited pro forma condensed combined statement of operations described in Item 9.01(b)
This excerpt taken from the EYE 8-K filed Aug 4, 2008.

EXHIBIT INDEX

 

Exhibit No.

    
99.1    Press release, dated August 4, 2008, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Jun 4, 2008.

EXHIBIT INDEX

 

Exhibit No.

   
99.1   2004 Stock Incentive Plan, as amended and restated on May 29, 2008.
This excerpt taken from the EYE 10-Q filed May 7, 2008.

INDEX

 

PART I - FINANCIAL INFORMATION

   3

Item 1.

   Financial Statements    3

(A).

   Unaudited Consolidated Statements of Operations - Three Months Ended March 28, 2008 and March 30, 2007    3

(B).

   Unaudited Consolidated Balance Sheets - March 28, 2008 and December 31, 2007    4

(C).

   Unaudited Consolidated Statements of Cash Flows - Three Months Ended March 28, 2008 and March 30, 2007    5

(D).

   Notes to Unaudited Consolidated Financial Statements    6

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    18
   Certain Factors and Trends Affecting AMO and Its Businesses    23

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    24

Item 4.

   Controls and Procedures    27

PART II - OTHER INFORMATION

   27

Item 1.   

   Legal Proceedings    27

Item 1A.

   Risk Factors    27

Item 2.   

   Unregistered Sales of Equity Securities and Use of Proceeds    28

Item 6.   

   Exhibits    29

Note:     

  

Items 3, 4 and 5 of Part II are omitted because they are not applicable.

  

Signatures

      30

Exhibit Index

      31

EXHIBIT 10.1

     

EXHIBIT 31.1

     

EXHIBIT 31.2

     

EXHIBIT 32.1

     

 

2


Table of Contents
This excerpt taken from the EYE 8-K filed May 1, 2008.

EXHIBIT INDEX

 

Exhibit
No.

    
99.1    Press release, dated May 1, 2008, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Feb 14, 2008.

EXHIBIT INDEX

 

Exhibit No.

    
99.1   

Press release, dated February 14, 2008, issued by Advanced Medical Optics, Inc.

This excerpt taken from the EYE 8-K filed Dec 5, 2007.

EXHIBIT INDEX

 

Exhibit
No.
    
99.1    Agreement, dated December 4, 2007, among Advanced Medical Optics, Inc., ValueAct Capital Master Fund, L.P., ValueAct Capital Master Fund III, L.P., VA Partners I, LLC, VA Partners III, LLC, ValueAct Capital Management, L.P., ValueAct Capital Management, LLC, ValueAct Holdings, L.P., ValueAct Holdings GP, LLC, Jeffrey W. Ubben, George F. Hamel, Jr., Peter H. Kamin, G. Mason Morfit, Todd Bourell, Gregory P. Spivy, Kelly Barlow, Allison Bennington, Briana Curran and Ronald Yee.
99.2    Press release dated December 5, 2007 announcing the appointments of Messrs. Heinrich and Morfit to the Advanced Medical Optics, Inc. Board of Directors.
This excerpt taken from the EYE 10-Q filed Nov 8, 2007.

INDEX

 

PART I – FINANCIAL INFORMATION    4
          Item 1.   Financial Statements    4
               (A).   Unaudited Consolidated Statements of Operations - Three Months and Nine Months Ended September 28, 2007 and September 29, 2006    4
               (B).   Unaudited Consolidated Balance Sheets - September 28, 2007 and December 31, 2006    5
               (C).   Unaudited Consolidated Statements of Cash Flows - Nine Months Ended September 28, 2007 and September 29, 2006    6
               (D).   Notes to Unaudited Consolidated Financial Statements    7
          Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations    23
    Certain Factors and Trends Affecting AMO and Its Businesses    32
          Item 3.   Quantitative and Qualitative Disclosures About Market Risk    33
          Item 4.   Controls and Procedures    35
PART II – OTHER INFORMATION    35
          Item 1.   Legal Proceedings    35
          Item 1A.   Risk Factors    36
          Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds    38
          Item 6.   Exhibits    38
          Note:   Items 3, 4 and 5 of Part II are omitted because they are not applicable.   
Signatures    39
Exhibit Index    40

 

3


Table of Contents
This excerpt taken from the EYE 10-Q filed Nov 7, 2007.

INDEX

 

PART I – FINANCIAL INFORMATION    3
          Item 1.   Financial Statements    3
               (A).   Unaudited Consolidated Statements of Operations - Three Months and Nine Months Ended September 28, 2007 and September 29, 2006    3
               (B).   Unaudited Consolidated Balance Sheets - September 28, 2007 and December 31, 2006    4
               (C).   Unaudited Consolidated Statements of Cash Flows - Nine Months Ended September 28, 2007 and September 29, 2006    5
               (D).   Notes to Unaudited Consolidated Financial Statements    6
          Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations    22
    Certain Factors and Trends Affecting AMO and Its Businesses    31
          Item 3.   Quantitative and Qualitative Disclosures About Market Risk    32
          Item 4.   Controls and Procedures    34
PART II – OTHER INFORMATION    34
          Item 1.   Legal Proceedings    34
          Item 1A.   Risk Factors    35
          Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds    37
          Item 6.   Exhibits    37
          Note:   Items 3, 4 and 5 of Part II are omitted because they are not applicable.   
Signatures    38
Exhibit Index    39

 

2


Table of Contents
This excerpt taken from the EYE 8-K filed Oct 25, 2007.

EXHIBIT INDEX

 

Exhibit No.    
99.1   Press release, dated October 25, 2007, issued by Advanced Medical Optics, Inc.
This excerpt taken from the EYE 8-K filed Aug 2, 2007.

EXHIBIT INDEX

 

Exhibit
No.
    
99.1    Press release, dated August 2, 2007, issued by Advanced Medical Optics, Inc.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki